SHENZHEN, China, Aug. 18, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, proudly announced today that it was granted the COTTON USA Mark license by Cotton Council International ("CCI") for its PurCotton® products, which use and contain 100% U.S.-grown cotton. According to CCI, all licensed products must contain at least 50 percent U.S.-grown cotton out of the cotton content with superior quality and reasonable selling price if sold outside the United States and 100% of the cotton must be made from U.S. cotton fiber if sold in the United States. After a long series of stringent verification and inspection process by Wakefield Inspection Services Ltd, one of the most famous independent inspection companies in the world specializing in the classification of cotton, Winner Medical was verified and recognized for using 100% U.S. cotton in its PurCotton® branded medical and consumer products, not only making the Company one of the few which may use Cotton USA Mark internationally, but more important, the only company in China which may use Cotton USA Mark for products sold in the U.S. market, echoing the CCI's slogan as "Look for the Cotton USA Mark only on quality pure cotton products." Jianquan Li, chief executive officer and director at Winner Medical comments, "We are excited to become the only domestic licensee that may use Cotton USA Mark in China market and overseas markets; such recognition represents the quality, versatility and value of our products. With growing majorities of consumers perceiving U.S. cotton-containing finished goods to be more durable, comfortable and stylish, our group would be able to deepen the expansion of international medical market and consumer market in China for PurCotton® products, while further enhancing our partnership with CCI." About Winner Medical: Winner Medical is a leading medical disposable products manufacturer in China, with business operations consisting of manufacturing, researching, developing and marketing cotton-based medical dressings and medical disposables, as well as consumer products. The Company has fourteen wholly-owned operating subsidiaries and three joint ventures, which manufacture tailored medical disposables and dressings, as well as non-woven fabric made from 100% natural cotton. With a vertically integrated supply chain ranging from spinning fabric to finished goods, the Company provides its customers with a wide range of products, from surgical and wound care to consumer products. The Company sells and markets its medical products and 100% natural cotton non-woven jumbo rolls in China and abroad. For nine consecutive years, the Company has been ranked as one of the top medical dressing exporters in China, with the United States, Europe, China and Japan being its most important markets. In addition, the Company distributes finished cotton non-woven consumer products under its own "PurCotton" brand name in China. With more than 20 years of international experience in the medical dressings and disposables field, the Company has a deep market understanding. This provides Winner Medical with a solid foundation upon which it plans to expand by growing its medical grade 100% cotton retail business. To learn more about Winner Medical, please visit Winner Medical's website at: http://winnermedical.investorroom.com. Forward-Looking Statements: This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objectives and statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions and involve known and unknown, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.
Shares of Winner Medical Group (Nasdaq:WWIN) have taken a tremendous swing upward. The stock is trading at $4.10 as of 9:39 a.m. ET, 20.6% above Friday's closing price of $3.40. Volume is at 23,231, 1.8 times the daily average of 13,100.